Showing results (31-40 of 113) with videos related to
Sort By:
Pageof 12
Antimicrobial Agents and Chemotherapy|December 15, 2020
Population Pharmacokinetics of Tenofovir in Pregnant and Postpartum Women Using Tenofovir Disoproxil FumarateAhizechukwu C Eke, Kensuke Shoji, Brookie M Best, et al.CPT: Pharmacometrics & Systems Pharmacology|June 20, 2019
Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal DosingJos Lommerse, Diana Clarke, Thomas Kerbusch, et al.Antimicrobial Agents and Chemotherapy|September 26, 2007
Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infantsAdriana H Tremoulet, Edmund V Capparelli, Parul Patel, et al.Antimicrobial Agents and Chemotherapy|March 29, 2017
Pharmacokinetics and Placental Transfer of Elvitegravir, Dolutegravir, and Other Antiretrovirals during PregnancyBassam H Rimawi, Erica Johnson, Augustine Rajakumar, et al.Antimicrobial Agents and Chemotherapy|December 31, 2008
Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapyMark Mirochnick, Timothy Thomas, Edmund Capparelli, et al.AIDS (London, England)|March 3, 2006
Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmissionJ Brooks Jackson, Teresa Parsons, Philippa Musoke, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 21, 2005
Safety and pharmacokinetics of nelfinavir coadministered with zidovudine and lamivudine in infants during the first 6 weeks of lifeMark Mirochnick, Alice Stek, Midnela Acevedo, et al.The Journal of Pediatrics|January 10, 2003
Pharmacokinetics and tolerance of zidovudine in preterm infantsEdmund V Capparelli, Mark Mirochnick, Wayne M Dankner, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2020
Antenatal Intracellular Concentrations of Tenofovir Diphosphate and Emtricitabine Triphosphate and Associations Between Tenofovir Diphosphate and Severe Adverse Pregnancy Outcomes: IMPAACT-PROMISE (1077BF) TrialJim Aizire, Kristina M Brooks, Mark Mirochnick, et al.The Pediatric Infectious Disease Journal|November 1, 2017
A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing GuidelinesJorge A Pinto, Edmund V Capparelli, Meredith Warshaw, et al.Pageof 12